DNA-PKcs inhibitor AZD7648 reveals gRNA cross-contaminants and enhanced sensitivity of genome engineering off-target activity in HSPCs
Here, we quantify the mutational burden associated with end joining inhibitor compounds (ART558 and/or AZD7648).